180 Life Sciences CEO James Woody resigns; Blair Jordan named Interim CEO

FORUM MARKETS Inc

CEO James Woody resigned May 7; receives $50K cash, 25K fully-vested shares, contingency bonus of $50K.
CSO Jonathan Rothbard resigned; gets $200 cash, then consulted at $150/hr for 6 months.
Executive Chairman Lawrence Steinman forgave all accrued compensation; stepped down to board member.
Blair Jordan appointed Interim CEO via consulting firm at $216K/yr plus $250K change-of-control bonus.
Board set non-executive comp: $50K annual retainer, $15K committee chair, $25K for Strategy Committee.

item 1.01 item 5.02 item 1.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Jonathan Rothbard

Chief Scientific Officer

FRMM · FORUM MARKETS Inc

Effective: 2024-05-07
Filed: May 9, 2024, 7:59 PM ET

On May 7, 2024, Dr. Jonathan Rothbard resigned as Chief Scientific Officer of the Company effective the same date.

Departed

Dr. James N. Woody

Chief Executive Officer (Principal Executive Officer)

FRMM · FORUM MARKETS Inc

Effective: 2024-05-07
Filed: May 9, 2024, 7:59 PM ET

On May 7, 2024, Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer), and as a member of the Board of Directors, of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) effective the same date

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Jonathan Rothbard resigned as Chief Scientific Officer at FORUM MARKETS Inc.

Action: resigned
Role: Chief Scientific Officer

Exact text from the filing

On May 7, 2024, Dr. Jonathan Rothbard resigned as Chief Scientific Officer of the Company effective the same date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer) at FORUM MARKETS Inc.

Action: resigned
Role: Chief Executive Officer (Principal Executive Officer)

Exact text from the filing

On May 7, 2024, Dr. James N. Woody resigned as Chief Executive Officer (Principal Executive Officer), and as a member of the Board of Directors, of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”) effective the same date

View on SEC.gov

FORUM MARKETS Inc filing history →

Source: SEC EDGAR

accession 0001213900-24-041030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.